These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 25957861)

  • 1. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma.
    Rubenstein JH; Shaheen NJ
    Gastroenterology; 2015 Aug; 149(2):302-17.e1. PubMed ID: 25957861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal Adenocarcinoma: Screening, Surveillance, and Management.
    Mansour NM; Groth SS; Anandasabapathy S
    Annu Rev Med; 2017 Jan; 68():213-227. PubMed ID: 27618753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus.
    Ishihara R; Goda K; Oyama T
    J Gastroenterol; 2019 Jan; 54(1):1-9. PubMed ID: 29961130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal adenocarcinoma and Barrett's esophagus.
    Sayana H; Wani S; Sharma P
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):157-69. PubMed ID: 17557044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
    Kamboj AK; Katzka DA; Iyer PG
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.
    Gamboa AM; Kim S; Force SD; Staley CA; Woods KE; Kooby DA; Maithel SK; Luke JA; Shaffer KM; Dacha S; Saba NF; Keilin SA; Cai Q; El-Rayes BF; Chen Z; Willingham FF
    Cancer; 2016 Jul; 122(14):2150-7. PubMed ID: 27142247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
    Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
    Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic Management of Early Esophageal Cancer.
    Barnes JA; Willingham FF
    J Clin Gastroenterol; 2015 Sep; 49(8):638-46. PubMed ID: 26125458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
    Blevins CH; Iyer PG
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.
    Codipilly DC; Chandar AK; Singh S; Wani S; Shaheen NJ; Inadomi JM; Chak A; Iyer PG
    Gastroenterology; 2018 Jun; 154(8):2068-2086.e5. PubMed ID: 29458154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of T1b esophageal adenocarcinoma patients.
    Tian J; Prasad GA; Lutzke LS; Lewis JT; Wang KK
    Gastrointest Endosc; 2011 Dec; 74(6):1201-6. PubMed ID: 22000793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal cancer prevention, cure, and palliation.
    Burdick JS
    Semin Gastrointest Dis; 2000 Jul; 11(3):124-33. PubMed ID: 10950458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: Esophageal Adenocarcinoma: Updates of Current Status.
    Lam AK
    Methods Mol Biol; 2018; 1756():1-6. PubMed ID: 29600355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic therapy in early adenocarcinomas (Barrett's cancer) of the esophagus.
    Knabe M; May A; Ell C
    J Dig Dis; 2015 Jul; 16(7):363-9. PubMed ID: 26031930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.
    Whiteman DC; Appleyard M; Bahin FF; Bobryshev YV; Bourke MJ; Brown I; Chung A; Clouston A; Dickins E; Emery J; Eslick GD; Gordon LG; Grimpen F; Hebbard G; Holliday L; Hourigan LF; Kendall BJ; Lee EY; Levert-Mignon A; Lord RV; Lord SJ; Maule D; Moss A; Norton I; Olver I; Pavey D; Raftopoulos S; Rajendra S; Schoeman M; Singh R; Sitas F; Smithers BM; Taylor AC; Thomas ML; Thomson I; To H; von Dincklage J; Vuletich C; Watson DI; Yusoff IF
    J Gastroenterol Hepatol; 2015 May; 30(5):804-20. PubMed ID: 25612140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epidemiology of Esophageal Adenocarcinoma.
    Coleman HG; Xie SH; Lagergren J
    Gastroenterology; 2018 Jan; 154(2):390-405. PubMed ID: 28780073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endoscopic diagnosis and staging of oesophageal adenocarcinoma.
    Bergman JJ
    Best Pract Res Clin Gastroenterol; 2006; 20(5):843-66. PubMed ID: 16997165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.